Xeltis successfully passes evaluation phase for €10million investment from European Innovation Council Xeltis announces that it has successfully passed the evaluation phase of the 2025 European Innovation Council (‘EIC’) STEP Scale-Up call program, and is set to secure a €10 million equity investment from the EIC, subject to an award decision by the European Commission […]
It’s no secret that 2025 is turning into a tricky year for life science companies looking to raise cash. Political and economic uncertainty has fed through into a ‘risk-off’ environment. So, when DeepMind spin-out Isomorphic Labs, a London-based AI drug development company, announced last week (March 31) that it had pocketed a huge $600 million […]
If a good rule of thumb for a conference is how full the hall is at the end of the day compared to the start, then the 21st Anglonordic Life Science Conference held last Thursday, attended by well over 300 people, was a resounding success. Maybe it was still full because attendees were keen to […]
Novo Holdings posts record total income and investment returns of DKK 60 billion (€8.0 billion) in 2024 Novo Holdings announced its financial results for 2024, with record returns from its Investment Portfolio and growth of the Novo Group companies driving Total Income and Investment Returns to DKK 60 billion (€8.0 billion) for 2024, up from […]
